NCT04335045 - Phase I Study of PH100 (Ecklonia Cava Phlorotannins) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 25, 2013

Primary Completion Date

December 8, 2014

Study Completion Date

December 8, 2014

Conditions

Safety Issues

Interventions

DRUG

Placebo

1\~8 Placebo capsule(s) corresponding to each PH100 dose

DRUG

PH100 100mg

1 x 100 mg PH100 oral capsule

DRUG

PH100 200mg

1 x 200 mg PH100 oral capsule

DRUG

PH100 400mg

2 x 200 mg PH100 oral capsules

DRUG

PH100 800mg

4 x 200 mg PH100 oral capsules

DRUG

PH100 1200mg

6 x 200 mg PH100 oral capsules

DRUG

PH100 1600mg

8 x 200 mg PH100 oral capsules

Trial Locations (1)

Worldwide Clinical Trials Early Phase Services, LLC, San Antonio